HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L Favennec Selected Research

L Favennec Research Topics

Disease

5Infections
12/2015 - 12/2000
3Cryptosporidiosis
03/2020 - 02/2006
2Diarrhea
03/2020 - 08/2016
2Giardiasis
09/2001 - 06/2001
1Multiple Sclerosis
03/2020
1Lymphopenia (Lymphocytopenia)
03/2020
1Cystic Fibrosis (Mucoviscidosis)
03/2012
1Phototoxic Dermatitis (Phototoxicity)
03/2012
1Hypersensitivity (Allergy)
11/2011
1Weight Gain
11/2011
1Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
10/2011
1Neoplasms (Cancer)
10/2011
1Cysts
04/2011
1Myocarditis (Carditis)
03/2008
1Trichinellosis
03/2008
1Cutaneous Leishmaniasis
07/2006
1Polymyositis
07/2006
1Uveitis
04/2006
1Body Weight (Weight, Body)
11/2005
1Fascioliasis
01/2003
1Acquired Immunodeficiency Syndrome (AIDS)
06/2001

Drug/Important Bio-Agent (IBA)

6nitazoxanide (NTZ)FDA Link
08/2016 - 06/2001
2CytokinesIBA
07/2006 - 12/2000
2Paromomycin (Paromomycin Sulfate)FDA LinkGeneric
02/2006 - 11/2005
2Metronidazole (Metric)FDA LinkGeneric
09/2001 - 06/2001
1Fingolimod Hydrochloride (FTY720)FDA Link
03/2020
1Disinfectants (Biocides)IBA
12/2015
1Voriconazole (Vfend)FDA LinkGeneric
03/2012
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
11/2011
1Octreotide (Sandostatin)FDA LinkGeneric
11/2011
1Particulate MatterIBA
04/2011
1TroponinIBA
03/2008
1Prednisone (Sone)FDA LinkGeneric
07/2006
1SteroidsIBA
07/2006
13- (3- bromophenyl)- 5,7- dihydroxy- 4- oxo- 4H- chromene- 2- carboxylic acid ethyl esterIBA
11/2005
1SuspensionsIBA
09/2001
1Albendazole (Albenza)FDA Link
06/2001
1Transforming Growth Factor beta (TGF-beta)IBA
12/2000
1Interleukin-8 (Interleukin 8)IBA
12/2000
1ChemokinesIBA
12/2000
1Chemokine CCL5IBA
12/2000

Therapy/Procedure

3Therapeutics
08/2016 - 01/2002
1Aftercare (After-Treatment)
03/2020
1Organ Transplantation
10/2011
1Vitrectomy
04/2006